In an in vivo preclinical melanoma model, inhibition of N-cadherin function with a cyclic pentapeptide combined with chemotherapy led to enhanced tumor cell apoptosis and inhibition of tumor growth [42]. The gene discussed is CDH2; the disease is melanoma.